| Year | Country | Species | Assay | References |
|---|---|---|---|---|
| Mastomys | ||||
| 2014 | Guinea | Mastomys erythroleucus | Serology | Fichet-Calvet E, 2014 |
| 2018 | Nigeria | Mastomys erythroleucus | PCR | Olayemi, 2018 |
| 1974 | Sierra Leone | Mastomys natalensis | Virus Culture | Monath, 1974 |
| 1974 | Sierra Leone | Mastomys natalensis | Culture | Monath, 1974 |
| 1975 | Nigeria | Mastomys natalensis | Culture | Wulff, 1975 |
| 2008 | Guinea | Mastomys natalensis | PCR | Fichet-Calvet, 2008 |
| 2014 | Guinea | Mastomys natalensis | Serology | Fichet-Calvet E, 2014 |
| 1988 | Senegal | Mastomys spp. | Serology | Saluzzo, 1988 |
| Mus | ||||
| 2018 | Nigeria | Mus baoulei | Serology | Olayemi, 2018 |
| 2019 | Benin | Mus baoulei | PCR | Anges Yadouleton, 2019 |
| 1975 | Nigeria | Mus minutoides | Virus Culture | Wulff, 1975 |
| 1975 | Nigeria | Mus minutoides | Culture | Wulff, 1975 |
| 2014 | Guinea | Mus minutoides | Serology | Fichet-Calvet E, 2014 |
| 1988 | Senegal | Mus musculus | Serology | Saluzzo, 1988 |
| 2011 | CĂ´te d'Ivoire | Mus setulosus | Serology | Coulibaly-N'Golo, 2011 |
| Rattus | ||||
| 1975 | Nigeria | Rattus rattus | Virus Culture | Wulff, 1975 |
| 1975 | Nigeria | Rattus rattus | Culture | Wulff, 1975 |
| 2018 | Nigeria | Rattus rattus | Serology | Olayemi, 2018 |
| Arvicanthis | ||||
| 1988 | Senegal | Arvicanthis niloticus | Serology | Saluzzo, 1988 |
| Gerbilliscus | ||||
| 1988 | Senegal | Gerbilliscus kempii | Serology | Saluzzo, 1988 |
| Crocidura | ||||
| 2011 | CĂ´te d'Ivoire | Crocidura spp. | Serology | Coulibaly-N'Golo, 2011 |
| Lophuromys | ||||
| 2011 | CĂ´te d'Ivoire | Lophuromys sikapusi | Serology | Coulibaly-N'Golo, 2011 |
| Lemniscomys | ||||
| 2014 | Guinea | Lemniscomys striatus | Serology | Fichet-Calvet E, 2014 |
| Praomys | ||||
| 2014 | Guinea | Praomys daltoni | Serology | Fichet-Calvet E, 2014 |
| 2018 | Nigeria | Praomys misonnei | Serology | Olayemi, 2018 |
| 2014 | Guinea | Praomys rostratus | Serology | Fichet-Calvet E, 2014 |
| Hylomyscus | ||||
| 2016 | Nigeria | Hylomyscus pamfi | PCR | Olayemi, 2016 |
| 2018 | Nigeria | Hylomyscus pamfi | Serology | Olayemi, 2018 |
| Malacomys | ||||
| 2021 | Sierra Leone | Malacomys edwardsi | Serology | Bangura, 2021 |
David Simons
Zoonoses, Infectious Diseases and Antimicrobial Resistance
Welcome to my personal website!
I am an epidemiologist and infectious disease ecologist. Currently a Postdoctoral Scholar at Penn State University working on the SCAPES project in Nigeria, I am transitioning to an independent role as the incoming Birgitta Sintring Fellow at Uppsala University in Sweden.
My research programme investigates the ecological and anthropogenic drivers of zoonotic viral spillover. I have organised my work into research themes accessible by selecting the headings below or in the navigation bar. You can read more about my clinical background and academic journey in the About me section.
đ˘ Recent Highlights
- Grant Award: Awarded the Birgitta Sintring Fellowship to investigate indirect contact networks in bank voles at Uppsala University (commencing Sept 2026).
- New Publication: A âOne Health Trial Designâ to accelerate Lassa fever vaccines published in Nature Medicine.
- Forthcoming: The Socio-economic Shield Limits Lassa Virus Spillover in Urban West Africa in press at Epidemiology & Infection.
Rodent-Borne Zoonoses
My primary research focuses on the complex ecology and epidemiology of viruses transmitted by rodents. This work combines field ecology, molecular diagnostics, and mathematical modelling to understand the mechanisms of viral spillover and inform public health interventions.
Lassa Fever
Lassa Fever is a zoonotic infectious disease, endemic across much of West Africa, caused by Mammarenavirus lassaense (LASV). It is classed as a Viral Haemorrhagic Fever - similar to Ebola Virus - there are no current effective treatments for individuals infected with this virus and no licensed vaccines. Human cases of disease are regularly reported from Nigeria, Sierra Leone, Liberia and Guinea. Sporadic cases are reported from other West African countries, including; Benin, Togo, Mali and Ghana. The annual incidence of disease is not known with an estimated 100-900,000 cases annually. Epidemiological studies funded by the Coalition for Epidemic Preparedness Innovations are ongoing (ENABLE 1.0, ENABLE 1.5), these will help local public health agencies understand the true scale of this disease.
The zoonotic hosts of LASV are rodent species, primarily Mastomys natalensis (the multimammate mouse). Although virus (6) or evidence of prior viral infection (16) has been detected in additional species across the endemic region. The multimammate mouse is found throughout sub-Saharan Africa although this pathogen is limited to the western extent of its range. The reasons behind this are not well understood and this raises concerns that the endemic range of this pathogen has the potential to expand across a greater region.
My research focusses on the ecology of rodent species within the endemic region and whether a better understanding of host dynamics can help us to quantify the risk of pathogen spillover into human populations. Understanding dynamics of both the host and virus will hopefully enable more targeted public health responses within the communities that need them most.
Rodent Ecology
Underpinning much of my research is a fundamental interest in rodent ecology. Understanding the population dynamics, community structure, and behavioural ecology of host species is critical for predicting disease risk. This theme explores my work on host ecology independent of a specific pathogen system.
It also houses my upcoming independent research programme, launching at Uppsala University, which focuses on developing microbial sensors to investigate the indirect detection of contact networks among bank voles. By mapping these hidden networks, we aim to better understand the environmental transmission dynamics of rodent-borne viruses.
Strategy & Policy
This theme translates ecological research into high-level frameworks for disease control and policy recommendations. Recent highlights include outlining an integrated âOne Health Trial Designâ framework to accelerate Lassa fever vaccines (published in Nature Medicine) and establishing a set of intrinsically safe design commitments for transmissible vaccines published in Science.
Open Science and Data Tools
I am a strong proponent of FAIR data principles and reproducibility in computational ecology. Rather than extracting data behind closed doors, I focus on building open-source infrastructure for the wider research community.
- Data Standards: I recently co-authored a minimum data standard for wildlife disease research published in Scientific Data, aimed at harmonising global surveillance efforts. I am involved in review exploring the use of geographic Ecological Momentary Assessments in addictive substance research, you can read our pre-registration here.
- Public Datasets: All my spatial ecology and trapping data are hosted on open platforms, including GBIF and the PHAROS database.
- Codebases & Apps: I maintain the open-source R codebase and interactive Shiny web applications for Project ArHa, allowing researchers to easily query and visualise global arenavirus and hantavirus data. You can explore my reproducible analysis pipelines on my GitHub.
Other Major Disease Systems
mpox
mpox is an endemic zoonosis, caused by the mpox virus (MPXV). Despite the name, the primary zoonotic reservoir is unknown, although several species are suspected as caompetent reservoirs. The virus has been isolated from wild animals on two occasions, first from a Rope Squirrel (Funisciurus anerythrus) and second from a Sooty Mangeby (Cercocebus atys). Several other species, including shrews, rodents and pigs, have been identified to have antibodies against the virus suggesting prior infection.
| Common name | Scientific name | Country | References |
|---|---|---|---|
| Virus Isolation | |||
| Rope squirrel | Funisciurus anerythrus | Democratic Republic of Congo (DRC) | Khodakevich et al. 1986 |
| Sooty mangabey | Cercocebus atys | Cote d'Ivoire | RadoniÄ et al. 2014 |
| Antibody Detection | |||
| Rope squirrel | Funisciurus anerythrus | DRC, Ghana, | Reynolds et al. 2010 |
| Giant pouched rats | Cricetomys emini | Ghana, DRC | Reynolds et al. 2010 |
| Sun squirrels | Heliociurus spp | Ghana | Reynolds et al. 2010 |
| Elephant shrews | Petrodromus tetradactylus | DRC | Hutin et al. 2001 |
| Domestic pigs | Sus scrofa | DRC | Hutin et al. 2001 |
| African dormouse | Graphiurus lorraineus | DRC | Doty et al. 2017 |
| Rusty-nosed rat | Oenomys hypoxanthus | DRC | Doty et al. 2017 |
| Grivet | Cercopithecus aethiops | Cote d'Ivoire, Liberia, Ghana, Mali | Breman et al. 1977 |
| Mona monkey | Cercopithecus mona | Cote d'Ivoire, Liberia, Ghana, Mali | Breman et al. 1977 |
| Lesser spot-nosed monkey | Cercopithecus petaurista | Cote d'Ivoire, Liberia, Ghana, Mali | Breman et al. 1977 |
| Greater spot-nosed monkey | Cercopithecus nictitans | Cote d'Ivoire, Liberia, Ghana, Mali | Breman et al. 1977 |
| Western red colobus | Colobus badius | Cote d'Ivoire, Liberia, Ghana, Mali | Breman et al. 1977 |
| King colobus | Colobus polykomos | Cote d'Ivoire, Liberia, Ghana, Mali | Breman et al. 1977 |
Human infections are reported from several Central and West African nations, including the Democratic Republic of Congo, Nigeria and Cameroon. Reported cases have been increasing since the elimination of Smallpox and the end of routine vaccination against this virus. The Smallpox vaccine was found to provide some protection against Monkeypox disease and waning immunity in the region is suspected to be driving increasing human cases. Monkeypox transmission rarely occur outside of the endemic region, suggesting limited human-to-human transmission outside of endemic regions. In early 2022, a globally distributed outbreak was identified, predominantly in populations of gay or bisexual and other men who have sex with men.
My work with monkeypox has primarily been in my role as an epidemiologist with the UK Health Security Agency maintaining a linelist of cases and their contacts. With PANDORA-ID-NET we looked at what factors may be driving the recent outbreak.
COVID-19
COVID-19 is a disease caused by infection with the SARS-Coronavirus-2 virus. This novel coronavirus was identified from a cluster of clinically diagnosed viral pneumonia cases in Wuhan, China in late 2019. This viral epidemic was declared a pandemic in early 2020 following global transmission and rapidly rising confirmed cases. The pandemic has highlighted the interconnectedness of current society and the vulnerability to diseases of pandemic potential. Public health responses have included travel bans, quarantine of confirmed and suspected contacts and national or regional lockdowns. The WHO records over 600 million cases of this disease and in excess of 6.5 million deaths on their WHO Coronavirus Dashboard.
Vaccines were rapidly developed against this disease, although their reduced efficacy against more recently emerged viral variants has potentially reduced the protection that was expected from population level immunity. Effective treatments against this disease have been identified through global clinical trials, exemplified by the RECOVERY trial which provided evidence for the effectiveness of steroids, antivirals and antibody therapy.
My work with this disease includes some early modelling work on the potential international spread of the recently identified virus, involvement in the London School of Hygiene and Tropical Medicineâs Centre for Mathematical Modelling of Infectious Diseases COVID-19 Working Group, performing regular updates to a living review on the association of smoking and SARS-CoV-2 infection, working as an epidemiologist with the UKHSA on the emerging Omicron variant and clinical work as a member of the Infectious Diseases team at University College London Hospital.

Antimicrobial Resistance
Antimicrobial resistance is increasingly recognised as a threat to human health as effectiveness of treatment and prevention falls. My work in this theme relates to epidemiological monitoring of resistance patterns in food production in Malaysia and involvement in antimicrobial stewardship in clinical practice.
Other work
I have collected other projects I have worked on in this section.
African Swine Fever
African Swine Fever (ASF) is a highly contagious viral disease of domestic and wild pigs. Mortality is very high (up to 100%) and transmission is difficult to control. The virus can be transmitted through contact with environmental sources, fomites and infected meat products.
The virus forms a complex dynamic system including domesticated and farmed suids and wild boar, with the primary route of transmission through contaminated carcasses, meat products and fluids from infected swine alongside contaminated fomites. The presence of a wild reservoir population during the ongoing epidemic introduces challenges to the control of viral spread, particularly as this is occurring on a background of increasing wild board population densities particularly in Europe.
This project began as a summer internship with EcoHealth Alliance looking at whether reporting of cases from the World Animal Health Infromation System, maintained by the World Organisation for Animal Health could help us to quantify the risk of cases being detected in regions not previously reporting cases.
Digital Health
I collaborate with Olga Perski, typically providing some data-science support to her interests of smoking cessation through digital health interventions.
Peste des Petits Ruminants
Peste des petits ruminants is caused by a morbilivirus which affects goats, sheep and other small ruminants. It has been targeted for global eradication by 2030. I assist with current work designed to assess the sensitivity and specificity of current assays against this virus to support elimination campaigns.
Consultancy
In addition to my academic research, I provide independent expert consultancy services in quantitative epidemiology and disease modelling for international health organisations and the biotechnology industry. Detailed information on services and contact details can be found on the Consultancy page.